Prognostic biomarker SCNM1 is associated with immune infiltration and therapeutic response, and promotes tumor migration in hepatocellular carcinoma
Experimental and Therapeutic Medicine · 27.10.2026 · 32 (6) · 1-15
DOI: 10.3892/etm.2026.13345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Therapeutic Medicine, online erschienen am 27.10.2026. Verfasst von Lin Jia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China.
- Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050017, P.R. China.
Zitieren
APA
Jia, L., Liang, Z., Wen, J., Guo, H., He, S., & Peng, Y. (2026). Prognostic biomarker SCNM1 is associated with immune infiltration and therapeutic response, and promotes tumor migration in hepatocellular carcinoma. Experimental and Therapeutic Medicine, 32(6), 1-15. https://doi.org/10.3892/etm.2026.13345
Vancouver
Jia L, Liang Z, Wen J, Guo H, He S, Peng Y. Prognostic biomarker SCNM1 is associated with immune infiltration and therapeutic response, and promotes tumor migration in hepatocellular carcinoma. Experimental and Therapeutic Medicine. 2026;32(6):1-15. doi:10.3892/etm.2026.13345
BibTeX
@article{Jia2026,
author = {Jia, Lin and Liang, Ze and Wen, Junye and Guo, Huaibin and He, Shuai and Peng, Yanhui},
title = {Prognostic biomarker SCNM1 is associated with immune infiltration and therapeutic response, and promotes tumor migration in hepatocellular carcinoma},
journal = {Experimental and Therapeutic Medicine},
year = {2026},
volume = {32},
number = {6},
pages = {1--15},
doi = {10.3892/etm.2026.13345}
}
EUVIMED